159992 创新药
午间休市 07-30 11:30:00
资讯
新帖
简况
ETF午评 | 创新药板块继续上攻,港股通创新药ETF溢价上涨6%
格隆汇 · 26分钟前
ETF午评 | 创新药板块继续上攻,港股通创新药ETF溢价上涨6%
港股异动 | 复星医药(02196)再涨超4% 公司获纽科阿尔茨海默病创新药物AR1001独家许可权
智通财经 · 02:48
港股异动 | 复星医药(02196)再涨超4% 公司获纽科阿尔茨海默病创新药物AR1001独家许可权
交银国际:升三生制药(01530.HK)目标价至33港元 维持“买入”评级
智通财经 · 02:44
交银国际:升三生制药(01530.HK)目标价至33港元 维持“买入”评级
凯因科技涨5.08% 创新药集采预期催化资金博弈
智选洞察 · 01:49
凯因科技涨5.08% 创新药集采预期催化资金博弈
创新药,彻底疯了
北海茶客投研笔记 · 07-29 13:31
创新药,彻底疯了
【数据看盘】多只创新药概念股获机构加仓 游资、量化激烈博弈西藏天路
市场资讯 · 07-29 10:16
【数据看盘】多只创新药概念股获机构加仓 游资、量化激烈博弈西藏天路
北水动向|北水成交净买入127.2亿 北水再度加仓创新药概念 全天买入小米超16亿港元
智通财经 · 07-29 09:48
北水动向|北水成交净买入127.2亿 北水再度加仓创新药概念 全天买入小米超16亿港元
长春高新:子公司苯磺酸氨氯地平口服溶液用冻干粉获美国FDA批准上市
格隆汇 · 07-29 09:11
长春高新:子公司苯磺酸氨氯地平口服溶液用冻干粉获美国FDA批准上市
港股收评:午后回升!恒指小幅下跌0.15%,创新药涨幅抢眼,三胎概念股高开低走
格隆汇 · 07-29 08:21
港股收评:午后回升!恒指小幅下跌0.15%,创新药涨幅抢眼,三胎概念股高开低走
抗癌“创新药舰队”高歌猛进 助阿斯利康(AZN.US)业绩超预期
智通财经 · 07-29 08:02
抗癌“创新药舰队”高歌猛进 助阿斯利康(AZN.US)业绩超预期
福安药业:长效生长激素属于创新药但非公司主导研发
证券之星 · 07-29 07:45
福安药业:长效生长激素属于创新药但非公司主导研发
诚达药业:公司业务包含为客户提供创新药关键中间体CDMO服务
证券之星 · 07-29 07:42
诚达药业:公司业务包含为客户提供创新药关键中间体CDMO服务
健康元:我们正着重推进 PDE4 单靶点创新药物的研发,这款新药设计为吸入制剂,通过局部用药可规避 PDE4 抑制剂全身用药副作用较大的问题,同时能针对性抑制炎症因子释放
互动易 · 07-29 07:36
健康元:我们正着重推进 PDE4 单靶点创新药物的研发,这款新药设计为吸入制剂,通过局部用药可规避 PDE4 抑制剂全身用药副作用较大的问题,同时能针对性抑制炎症因子释放
健康元:持续加大创新药研发投入,多个1类创新药进入临床关键阶段
证券之星 · 07-29 07:34
健康元:持续加大创新药研发投入,多个1类创新药进入临床关键阶段
ETF今日收评 | 多只创新药相关ETF涨超4%,180治理等ETF跌超2%
每日经济新闻 · 07-29 07:29
ETF今日收评 | 多只创新药相关ETF涨超4%,180治理等ETF跌超2%
港股异动 | 药明巨诺-B(02126.HK)尾盘涨超36% 公司CAR-T产品将积极参加医保和商保创新药目录申报工作
智通财经 · 07-29 07:26
港股异动 | 药明巨诺-B(02126.HK)尾盘涨超36% 公司CAR-T产品将积极参加医保和商保创新药目录申报工作
ETF收评 | 创新药板块爆发,港股通创新药ETF涨超5%
格隆汇 · 07-29 07:12
ETF收评 | 创新药板块爆发,港股通创新药ETF涨超5%
全线大张!三大利好刺激,创新药赛道大爆发
券商中国 · 07-29 05:50
全线大张!三大利好刺激,创新药赛道大爆发
研报掘金丨中邮证券:贵州百灵盈利能力及控费能力显著提升,首予“买入”评级
格隆汇 · 07-29 05:27
研报掘金丨中邮证券:贵州百灵盈利能力及控费能力显著提升,首予“买入”评级
全市场独家品种·创新药ETF天弘(517380)飙涨4.56%,涨幅位居全市场第一
格隆汇 · 07-29 03:36
全市场独家品种·创新药ETF天弘(517380)飙涨4.56%,涨幅位居全市场第一
加载更多
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"159992","market":"SZ","secType":"STK","nameCN":"创新药","latestPrice":0.945,"timestamp":1753848525000,"preClose":0.939,"halted":0,"volume":370979437,"delay":0,"changeRate":0.0064,"floatShares":0,"shares":0,"eps":0,"marketStatus":"午间休市","change":0.006,"latestTime":"07-30 11:30:00","open":0.932,"high":0.952,"low":0.93,"amount":350000000,"amplitude":0.0234,"askPrice":0.945,"askSize":7995,"bidPrice":0.944,"bidSize":20242,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753851600000},"marketStatusCode":3,"adr":0,"adjPreClose":0.939,"symbolType":"fund","openAndCloseTimeList":[[1753839000000,1753846200000],[1753851600000,1753858800000]],"highLimit":1.033,"lowLimit":0.845,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":0.392534,"marketValue":0,"turnoverRate":0,"status":0,"floatMarketCap":0},"requestUrl":"/m/hq/s/159992","defaultTab":"news","newsList":[{"id":"2555709971","title":"ETF午评 | 创新药板块继续上攻,港股通创新药ETF溢价上涨6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555709971","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555709971?lang=zh_cn&edition=full","pubTime":"2025-07-30 11:43","pubTimestamp":1753847034,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["399300","BK4585","HSTECH","CRCL","159512","159992","BK4170","516860","BK4588","516570","159982","BK4600","159757","06978","HSCEI","YANG","LU1791807156.HKD","LU1861220207.SGD","399001","BK4614","159731","07226","159796","LU1668664300.SGD","EBON","LU1861217088.USD","BK4023","LU2360107671.USD","512170","399006","BK1161","BK1574","516100","516620","515120","159767","513060","516110","159828","BK4595","159323","LU0106831901.USD","516020","159870","159855","FDN","BK4550"],"gpt_icon":0},{"id":"2555099882","title":"港股异动 | 复星医药(02196)再涨超4% 公司获纽科阿尔茨海默病创新药物AR1001独家许可权","url":"https://stock-news.laohu8.com/highlight/detail?id=2555099882","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555099882?lang=zh_cn&edition=full","pubTime":"2025-07-30 10:48","pubTimestamp":1753843687,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,复星医药再涨超4%,截至发稿,涨4.3%,报20.15港元,成交额2.01亿港元。消息面上,复星医药公布,控股子公司复星医药产业与纽科签订许可协议,据此,复医药产业获授予AR1001子作为其活性成分的药物于约定许可区域及领域的开发、注册、生产及商业化权利。复星医药产业将就本次许可向纽科支付至多1.5亿人民币。纽科于2024年初从AriBio获得AR1001在大中华地区的独家权益,并与AriBio合作开展AR1001针对早期阿尔茨海默病患者的全球III期临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323468.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK0188","BK0183","06978","BK0096","BK0196","159992","BK0012","BK1191","BK0060","BK0239","BK1593","BK0028","BK0175","BK1161","600196","02196","BK1515","BK0187"],"gpt_icon":0},{"id":"2555096495","title":"交银国际:升三生制药(01530.HK)目标价至33港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2555096495","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555096495?lang=zh_cn&edition=full","pubTime":"2025-07-30 10:44","pubTimestamp":1753843449,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","06978","159992","01530","BK1574","BK1161","BK1583"],"gpt_icon":0},{"id":"2555093701","title":"凯因科技涨5.08% 创新药集采预期催化资金博弈","url":"https://stock-news.laohu8.com/highlight/detail?id=2555093701","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555093701?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:49","pubTimestamp":1753840140,"startTime":"0","endTime":"0","summary":"凯因科技股价大幅上涨,最新价36.00元/股,涨幅达5.08%。资金博弈与政策预期交织下的波动逻辑近期凯因科技净流入与资金面剧烈波动密切相关。截至7月29日,该股主力资金单日最高净流入达7337.9万元,次日即转为净流出4602万元,反映机构调仓行为加剧市场分歧。研发突破与商业化进程构筑估值中枢长期来看,凯因科技的核心竞争力取决于乙肝新药KW-027的临床进展。当前42.18倍动态市盈率显著高于行业均值,反映市场已部分透支创新预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730094906a46a8b79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730094906a46a8b79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688687","159992"],"gpt_icon":0},{"id":"2555805287","title":"创新药,彻底疯了","url":"https://stock-news.laohu8.com/highlight/detail?id=2555805287","media":"北海茶客投研笔记","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555805287?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:31","pubTimestamp":1753795861,"startTime":"0","endTime":"0","summary":"为什么茶客今年能成功预言创新药会形成抱团式的爆炒?三股抱团势力创新药的交易节奏和市值版图首先,从基本面来讲,创新药这个行业是真正在发生剧变的行业,是AH两市中为数不多真正有产业趋势的行业。这一点茶客之前讲过很多:中国创新药崛起之谜:从科学到工程学中国的创新药,到底发展到什么阶段了?毕竟在公募基金这种聪明人扎堆内卷的机构,如果这一次不能证明自己,就永远没有下一次机会了。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729214931a469ce08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729214931a469ce08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","01276","BK0239","06160","02197","06628","688235","600276","01228","01801","09926","159992"],"gpt_icon":0},{"id":"2555037695","title":"【数据看盘】多只创新药概念股获机构加仓 游资、量化激烈博弈西藏天路","url":"https://stock-news.laohu8.com/highlight/detail?id=2555037695","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555037695?lang=zh_cn&edition=full","pubTime":"2025-07-29 18:16","pubTimestamp":1753784160,"startTime":"0","endTime":"0","summary":" 沪深股通今日合计成交2334.31亿,其中恒瑞医药和宁德时代分居沪股通和深股通个股成交额首位。板块主力资金方面,医药板块主力资金净流入居首。期指持仓方面,IH合约空头减仓数量明显大于多头。龙虎榜方面,北方长龙获机构买入1.17亿;德科立获机构买入1.8亿;上海电影遭机构卖出超7000万;爱婴室遭机构卖出超4000万;云南锗业获国泰海通南京太平南路营业部净买入1.02亿;硕贝德遭一家量化席位卖出1亿。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-07-29/doc-inficsmt4692131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","BK1161","600326","BK0139","BK0235","BK0188","BK0101","159992","BK1574","BK0033"],"gpt_icon":0},{"id":"2555037898","title":"北水动向|北水成交净买入127.2亿 北水再度加仓创新药概念 全天买入小米超16亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555037898","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555037898?lang=zh_cn&edition=full","pubTime":"2025-07-29 17:48","pubTimestamp":1753782521,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,7月29日港股市场,北水成交净买入127.2亿港元,其中港股通(沪)成交净买入58.78亿港元,港股通(深)成交净买入68.42亿港元。北水加仓创新药概念。石药集团、信达生物分别获净买入6.51亿、5.14亿港元。锦欣生殖获净买入1.94亿港元。方案明确,从2025年1月1日起,对符合法律法规规定生育的3周岁以下婴幼儿发放补贴,至其年满3周岁。此外,国泰君安国际获净买入4.3亿港元,而南方恒生科技遭净卖出6787万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072917562797252739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072917562797252739&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1064130708.USD","09988","00981","81810","LU2148510915.USD","01951","BK0214","01093","LU1064131003.USD","SGXZ49509284.SGD","SGXZ81163826.USD","01801","159992","688981"],"gpt_icon":1},{"id":"2555039523","title":"长春高新:子公司苯磺酸氨氯地平口服溶液用冻干粉获美国FDA批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2555039523","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555039523?lang=zh_cn&edition=full","pubTime":"2025-07-29 17:11","pubTimestamp":1753780309,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0188","159992","BK0075","159938","BK1574","BK0057","BK0028","BK1161","000661","06978","BK0046","BK0239","BK1515","09939"],"gpt_icon":0},{"id":"2555035386","title":"港股收评:午后回升!恒指小幅下跌0.15%,创新药涨幅抢眼,三胎概念股高开低走","url":"https://stock-news.laohu8.com/highlight/detail?id=2555035386","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555035386?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:21","pubTimestamp":1753777290,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["METmain","09618","601288","06160","161726","HSCEI","MPNGY","BIDU","01024","02359","159992","BABA","03690","01398","TTTN","HHImain","03086","07226","MHImain","YANG","601939","JD","TCHmain","KSTmain","603259","01288","01810","HSI","HSImain","TCEHY","08496","MCHmain","HTCD.SI","02186","01530","399441","MIUmain","01801","688428","HSTECH","09969","601398","00700","01093","ONC","00939","688235","ALBmain","06978"],"gpt_icon":0},{"id":"2555332140","title":"抗癌“创新药舰队”高歌猛进 助阿斯利康(AZN.US)业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2555332140","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555332140?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:02","pubTimestamp":1753776160,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09939","BK1574","LU0109394709.USD","LU2236285917.USD","LU2456880835.USD","159992","LU2462157665.USD","LU1829250122.USD","BK4007","AZN","LU0320765992.SGD","BK1515","LU0889565916.HKD","06978","LU2417539215.USD","159938","BK4568","BK4588","BK1161","BK4585"],"gpt_icon":0},{"id":"2555403380","title":"福安药业:长效生长激素属于创新药但非公司主导研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2555403380","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555403380?lang=zh_cn&edition=full","pubTime":"2025-07-29 15:45","pubTimestamp":1753775112,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)07月29日在投资者关系平台上答复投资者关心的问题。投资者提问:公司的长效生长激素不属于一类化药吗??一类化药不就是创新药??福安药业回复:长效生长激素研发项目系公司子公司重庆庆余堂参股公司苏州优诺金公司的在研生物制品项目,该药品属于创新药,但其并非由公司主导进行研发的项目,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072900022054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300194","BK1574","BK0028","159992","BK1161","06978","BK0132","BK0060"],"gpt_icon":0},{"id":"2555033842","title":"诚达药业:公司业务包含为客户提供创新药关键中间体CDMO服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2555033842","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555033842?lang=zh_cn&edition=full","pubTime":"2025-07-29 15:42","pubTimestamp":1753774930,"startTime":"0","endTime":"0","summary":"证券之星消息,诚达药业(301201)07月29日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,公司在创新医药领域的优势在哪里,目前公司还有什么对外投资的项目诚达药业回复:尊敬的投资者您好,公司业务包含为客户提供创新药关键中间体CDMO服务;同时,公司于2024年布局生物细胞药物领域,拓展生物创新药管线,进展情况请关注公司后续披露的信息。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072900021454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1574","159992","BK1161","06978","301201"],"gpt_icon":0},{"id":"2555039426","title":"健康元:我们正着重推进 PDE4 单靶点创新药物的研发,这款新药设计为吸入制剂,通过局部用药可规避 PDE4 抑制剂全身用药副作用较大的问题,同时能针对性抑制炎症因子释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2555039426","media":"互动易","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555039426?lang=zh_cn&edition=full","pubTime":"2025-07-29 15:36","pubTimestamp":1753774560,"startTime":"0","endTime":"0","summary":"目前已上市的 PDE3/4 双靶点抑制剂创新药,其核心优势在于依托 PDE3 靶点发挥较强的支气管扩张作用,而在抗炎方面的效果相对有限,无法完全满足 COPD 患者对炎症控制的需求。因此,我们正着重推进 PDE4 单靶点创新药物的研发,这款新药设计为吸入制剂,通过局部用药可规避 PDE4 抑制剂全身用药副作用较大的问题,同时能针对性抑制炎症因子释放,恰好能弥补现有治疗中 “抗炎效果不足” 的短板,为患者提供更精准的炎症控制选择。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729155122a4692b36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729155122a4692b36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0046","BK0188","BK0028","159992","BK0114","BK0077","600380"],"gpt_icon":0},{"id":"2555033830","title":"健康元:持续加大创新药研发投入,多个1类创新药进入临床关键阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2555033830","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555033830?lang=zh_cn&edition=full","pubTime":"2025-07-29 15:34","pubTimestamp":1753774456,"startTime":"0","endTime":"0","summary":"公司近年来持续加大在创新药领域的研发投入,当前已有多个1类创新药和具有全球差异化竞争力的创新药项目进入临床关键阶段截止现在已布局二十余款1类创新药,其中超过10款已进入二期临床及以后阶段,各项目均按计划有序推进。COPD作为高发慢性呼吸疾病,患者数量庞大且持续增长,现有治疗中难以有效控制炎症,导致症状持续加重,反复急性发作等问题尚未解决,这些药物有望为这一领域带来新的治疗方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072900020517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1574","BK0046","BK0188","BK0028","159992","BK1161","06978","BK0077","BK0114","600380"],"gpt_icon":0},{"id":"2555929038","title":"ETF今日收评 | 多只创新药相关ETF涨超4%,180治理等ETF跌超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555929038","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555929038?lang=zh_cn&edition=full","pubTime":"2025-07-29 15:29","pubTimestamp":1753774152,"startTime":"0","endTime":"0","summary":"从板块来看,医药股集体大涨,CRO、创新药方向领涨,CPO等算力硬件股震荡走强,超级水电概念股午后反弹。ETF上涨方面,多只创新药相关ETF涨超4%。消息面上,近日,恒瑞医药与葛兰素史克公司达成合作协议,双方将共同开发至多12款创新药物。根据协议,GSK将向恒瑞医药支付5亿美元的首付款,后者还将有资格获得未来基于成功开发、注册和销售里程碑付款的潜在总金额约120亿美元。下跌方面,180治理ETF、德国ETF、法国CAC40ETF跌超2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729153248a6c754cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729153248a6c754cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0010","000021.SH","000021","159992","BK0028","BK0198","BK0214","BK0030"],"gpt_icon":0},{"id":"2555038377","title":"港股异动 | 药明巨诺-B(02126.HK)尾盘涨超36% 公司CAR-T产品将积极参加医保和商保创新药目录申报工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2555038377","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555038377?lang=zh_cn&edition=full","pubTime":"2025-07-29 15:26","pubTimestamp":1753773990,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159992","BK4022","BK1583","BK1161","BK1574","02126","06978","BK4230","CAR"],"gpt_icon":0},{"id":"2555080182","title":"ETF收评 | 创新药板块爆发,港股通创新药ETF涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555080182","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555080182?lang=zh_cn&edition=full","pubTime":"2025-07-29 15:12","pubTimestamp":1753773163,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["000001.SH","159561","BK1161","HSTECH","515120","150227","159992","399001","BK4614","HSCEI","FDN","515980","513030","399006","BK4550","399300","07226","BK1574","513080","BK4585","06978","BK4588","515290","159583","161121","YANG","159915","159982","510010"],"gpt_icon":0},{"id":"2555828710","title":"全线大张!三大利好刺激,创新药赛道大爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2555828710","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555828710?lang=zh_cn&edition=full","pubTime":"2025-07-29 13:50","pubTimestamp":1753768228,"startTime":"0","endTime":"0","summary":"创新药赛道大爆发。7月29日,A股、港股市场创新药板块再度全线爆发,多只个股大涨超10%。消息面上,创新药赛道大涨主要受业绩超预期、海外大订单与政策三大利好驱动。光大证券指出,考虑到部分创新药公司BD交易持续催化、细分赛道及正处于转型阶段的公司或有积极变化,应当积极关注板块高质量标的、增加板块配置。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507291350409724b29a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507291350409724b29a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","06127","LU1997245094.SGD","SBHMY","01530","03347","LU2488822045.USD","688221","06821","BK0028","LU0405327148.USD","GSK","BK0196","02359","LU1328615791.USD","159992","02096","603456","LU2328871848.SGD","688321","LU1064130708.USD","01276","BK0060","LU1969619763.USD","BK0183","LU1064131003.USD","LU1997245177.USD","603127","LU1655091616.SGD","LU1997244956.HKD","603367","600276","00853","LU2148510915.USD","BK0012","603229","01093","LU0405327494.USD","603259","BK0239","02186","01177","LU2495084118.USD"],"gpt_icon":0},{"id":"2555308411","title":"研报掘金丨中邮证券:贵州百灵盈利能力及控费能力显著提升,首予“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2555308411","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555308411?lang=zh_cn&edition=full","pubTime":"2025-07-29 13:27","pubTimestamp":1753766873,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1141","BK1576","BK1583","002424","BK0077","03347","BK1161","BK0239","BK1574","BK0183","BK0146","399441","161726","159992","BK0188","BK0028","161027","06978"],"gpt_icon":0},{"id":"2555089512","title":"全市场独家品种·创新药ETF天弘(517380)飙涨4.56%,涨幅位居全市场第一","url":"https://stock-news.laohu8.com/highlight/detail?id=2555089512","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555089512?lang=zh_cn&edition=full","pubTime":"2025-07-29 11:36","pubTimestamp":1753760164,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["600276","CXO","CYB","LU0719512351.SGD","BK4512","LU2286300806.USD","159982","LU0405327148.USD","LU0082616367.USD","07226","BK4614","159217","FDN","BK4532","HSCEI","LU1829250122.USD","BK0077","GSK.UK","BK0012","MU","515120","159938","BK0060","CXO.AU","300347","LU1997245094.SGD","LU1997245177.USD","LU1146622755.USD","MCNHmain","09939","06978","CNHmain","IE00B19Z3B42.SGD","03347","MUCmain","BK4543","GSK","300725","UCmain","159992","02359","HSTECH","LU1655091616.SGD","01276","399300","LU1969619763.USD","603259","YANG","BK4553","BK0229"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753848537006,"stockEarnings":[{"period":"1week","weight":0.0744},{"period":"1month","weight":0.2008},{"period":"3month","weight":0.281},{"period":"6month","weight":0.385},{"period":"1year","weight":0.5495},{"period":"ytd","weight":0.3472}],"compareEarnings":[{"period":"1week","weight":0.0078},{"period":"1month","weight":0.0542},{"period":"3month","weight":0.1008},{"period":"6month","weight":0.1105},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.077}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创新药(159992)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创新药(159992)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创新药,159992,创新药股票,创新药股票老虎,创新药股票老虎国际,创新药行情,创新药股票行情,创新药股价,创新药股市,创新药股票价格,创新药股票交易,创新药股票购买,创新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创新药(159992)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创新药(159992)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}